Investors often weigh the stability of established giants against the high-octane growth of market leaders

Legislative efforts in the United States to negotiate lower drug prices could also impact future revenue growth.

That has the company labeled a "value trap" by some analysts.

Bristol Myers Squibb discovers and delivers medicines for serious di.